Wall Street Financial Group »

Regeneron Pharmaceuticals shares owned by Wall Street Financial Group

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Wall Street Financial Group from 13F filings

Historical chart of Wall Street Financial Group investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Wall Street Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Wall Street Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $97k 125 772.64

More positions owned by Wall Street Financial Group

Vanguard World Inf Tech Etf (VGT)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
NVIDIA Corporation (NVDA)
Morgan Stanley Etf Trust Eaton Vance Tota (EVTR)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Ishares Semicdtr (SOXX)
Vanguard World Financials Etf (VFH)
Apple (AAPL)
Ishares Tr Core Us Aggbd Et (AGG)
Abrdn Etfs Bbrg All Comd K1 (BCI)
Select Sector Spdr Tr State Street Com (XLC)
Microsoft Corporation (MSFT)
Vanguard World Consum Dis Etf (VCR)
Amazon (AMZN)
Select Sector Spdr Tr State Street Ind (XLI)

View all positions for Wall Street Financial Group

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
Vanguard Capital Management
State Street Corporation
Dodge & Cox
Franklin Resources
Geode Capital Management
FMR
Nuveen
Loomis, Sayles and
Invesco
Vanguard Portfolio Management
Goldman Sachs Group
Capital World Investors
Susquehanna International

View all funds holding Regeneron Pharmaceuticals